Drug Discovery 정보학 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 모드별, 워크플로우별, 서비스별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Drug Discovery Informatics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Mode, By Workflow, By Services, By End User, By Region and Competition, 2020-2030F
상품코드:1878893
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 Drug Discovery 정보학 시장은 2024년에 34억 8,000만 달러로 평가되었으며, 2030년까지 CAGR 9.40%로 성장하여 59억 7,000만 달러에 달할 것으로 예측됩니다.
Drug Discovery 정보학은 Drug Discovery 프로세스 전반에 걸쳐 생성되는 방대하고 다양한 데이터를 관리, 분석, 해석하기 위해 계산 기법과 분석 툴을 적용하는 분야로, 이를 통해 잠재적 신약 후보물질 발굴 및 최적화 효율을 높일 수 있습니다. 시장 성장은 주로 제약 연구 및 개발에 대한 막대한 투자, 증가하는 과학 데이터의 양과 복잡성을 처리해야 하는 필요성, 신약 개발 기간 및 관련 비용 절감에 대한 지속적인 압력에 의해 주도되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
34억 8,000만 달러
시장 규모 : 2030년
59억 7,000만 달러
CAGR : 2025-2030년
9.4%
가장 빠르게 성장하는 부문
아웃소싱
최대 시장
북미
주요 시장 촉진요인
주요 시장 과제
주요 시장 동향
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 Drug Discovery 정보학 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
제공 형태별(자사내, 외부 위탁)
워크플로우별(Discovery, Development)
서비스별(배열 해석 플랫폼, 분자 모델링, 도킹, 임상시험 데이터 관리, 기타)
최종사용자별(제약·바이오테크놀러지 기업, 계약 연구기관(CRO), 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 Drug Discovery 정보학 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 Drug Discovery 정보학 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 Drug Discovery 정보학 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 Drug Discovery 정보학 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 Drug Discovery 정보학 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 Drug Discovery 정보학 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Dassault Systemes SE
IBM Corporation
Infosys Ltd.
Schrodinger Inc.
Jubilant Life Sciences NV
Aragen Lifescience Ltd.
Charles River Laboratories Inc.
Thermo Fisher Scientific Inc.
Clarivate Analytics LLC
PerkinElmer Inc.
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global Drug Discovery Informatics Market, valued at USD 3.48 Billion in 2024, is projected to experience a CAGR of 9.40% to reach USD 5.97 Billion by 2030. Drug discovery informatics involves the application of computational methods and analytical tools to manage, analyze, and interpret the extensive and varied data generated throughout the drug discovery process, thereby enhancing the efficiency of identifying and optimizing potential drug candidates. The market's growth is primarily driven by substantial investments in pharmaceutical research and development, a necessity to process the increasing volume and complexity of scientific data, and the continuous pressure to reduce drug development timelines and associated costs.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 3.48 Billion
Market Size 2030
USD 5.97 Billion
CAGR 2025-2030
9.4%
Fastest Growing Segment
Outsourced
Largest Market
North America
Key Market Drivers
The rapid proliferation of big data in drug discovery is a core driver accelerating the growth of the informatics market. The escalating volume and complexity of data generated from genomic sequencing, proteomics, and advanced experimental assays require sophisticated computational tools for effective data management, analysis, and interpretation. This expanding data ecosystem is driving strong demand for informatics platforms capable of integrating diverse datasets and transforming them into actionable insights for identifying and prioritising potential drug candidates. Reflecting the scale of this data generation, the report Genomics Market Size, Trends and Tailored Solutions for Personalized Medicine stated that the global genomics market was valued at USD 38.52 billion in 2024, underscoring the magnitude of information being produced and the corresponding need for high-performance informatics solutions to accelerate early-stage drug development.
Key Market Challenges
The complexity of data integration and persistent interoperability challenges across fragmented platforms and heterogeneous data sources pose a significant constraint on the growth of the Global Drug Discovery Informatics Market. The pharmaceutical industry produces vast volumes of diverse data across multiple workflows, including genomics, proteomics, and clinical trials. However, these datasets frequently remain siloed within disconnected systems, creating substantial barriers to standardisation, consolidation, and holistic analysis. This lack of seamless integration limits the ability to establish a unified and comprehensive research view, which is essential for accelerating drug candidate identification and optimisation.
Key Market Trends
The adoption of cloud-native informatics platforms represents a significant trend in the global drug discovery informatics market, moving away from on-premise infrastructure to scalable, accessible cloud-based solutions. This shift provides enhanced flexibility and computational power for managing and analyzing the vast datasets generated in drug discovery. According to a Pistoia Alliance survey published in September 2025, 80% of life sciences labs now utilize cloud data platforms, marking an increase from 70% in 2023. This growth underscores the industry's recognition of cloud benefits, including improved collaboration and reduced IT overheads.
Key Market Players
Dassault Systemes SE
IBM Corporation
Infosys Ltd.
Schrodinger Inc.
Jubilant Life Sciences NV
Aragen Lifescience Ltd.
Charles River Laboratories Inc.
Thermo Fisher Scientific Inc.
Clarivate Analytics LLC
PerkinElmer Inc.
Report Scope:
In this report, the Global Drug Discovery Informatics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Drug Discovery Informatics Market, By Mode:
In-house
Outsourced
Drug Discovery Informatics Market, By Workflow:
Discovery
Development
Drug Discovery Informatics Market, By Services:
Sequence Analysis Platforms
Molecular Modelling
Docking
Clinical Trial Data Management
Others
Drug Discovery Informatics Market, By End User:
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROS)
Others
Drug Discovery Informatics Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Drug Discovery Informatics Market.
Available Customizations:
Global Drug Discovery Informatics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Drug Discovery Informatics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Mode (In-house, Outsourced)
5.2.2. By Workflow (Discovery, Development)
5.2.3. By Services (Sequence Analysis Platforms, Molecular Modelling, Docking, Clinical Trial Data Management, Others)
5.2.4. By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROS), Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Drug Discovery Informatics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Mode
6.2.2. By Workflow
6.2.3. By Services
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Drug Discovery Informatics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Mode
6.3.1.2.2. By Workflow
6.3.1.2.3. By Services
6.3.1.2.4. By End User
6.3.2. Canada Drug Discovery Informatics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Mode
6.3.2.2.2. By Workflow
6.3.2.2.3. By Services
6.3.2.2.4. By End User
6.3.3. Mexico Drug Discovery Informatics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Mode
6.3.3.2.2. By Workflow
6.3.3.2.3. By Services
6.3.3.2.4. By End User
7. Europe Drug Discovery Informatics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Mode
7.2.2. By Workflow
7.2.3. By Services
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Drug Discovery Informatics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Mode
7.3.1.2.2. By Workflow
7.3.1.2.3. By Services
7.3.1.2.4. By End User
7.3.2. France Drug Discovery Informatics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Mode
7.3.2.2.2. By Workflow
7.3.2.2.3. By Services
7.3.2.2.4. By End User
7.3.3. United Kingdom Drug Discovery Informatics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Mode
7.3.3.2.2. By Workflow
7.3.3.2.3. By Services
7.3.3.2.4. By End User
7.3.4. Italy Drug Discovery Informatics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Mode
7.3.4.2.2. By Workflow
7.3.4.2.3. By Services
7.3.4.2.4. By End User
7.3.5. Spain Drug Discovery Informatics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Mode
7.3.5.2.2. By Workflow
7.3.5.2.3. By Services
7.3.5.2.4. By End User
8. Asia Pacific Drug Discovery Informatics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Mode
8.2.2. By Workflow
8.2.3. By Services
8.2.4. By End User
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Drug Discovery Informatics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Mode
8.3.1.2.2. By Workflow
8.3.1.2.3. By Services
8.3.1.2.4. By End User
8.3.2. India Drug Discovery Informatics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Mode
8.3.2.2.2. By Workflow
8.3.2.2.3. By Services
8.3.2.2.4. By End User
8.3.3. Japan Drug Discovery Informatics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Mode
8.3.3.2.2. By Workflow
8.3.3.2.3. By Services
8.3.3.2.4. By End User
8.3.4. South Korea Drug Discovery Informatics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Mode
8.3.4.2.2. By Workflow
8.3.4.2.3. By Services
8.3.4.2.4. By End User
8.3.5. Australia Drug Discovery Informatics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Mode
8.3.5.2.2. By Workflow
8.3.5.2.3. By Services
8.3.5.2.4. By End User
9. Middle East & Africa Drug Discovery Informatics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Mode
9.2.2. By Workflow
9.2.3. By Services
9.2.4. By End User
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Drug Discovery Informatics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Mode
9.3.1.2.2. By Workflow
9.3.1.2.3. By Services
9.3.1.2.4. By End User
9.3.2. UAE Drug Discovery Informatics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Mode
9.3.2.2.2. By Workflow
9.3.2.2.3. By Services
9.3.2.2.4. By End User
9.3.3. South Africa Drug Discovery Informatics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Mode
9.3.3.2.2. By Workflow
9.3.3.2.3. By Services
9.3.3.2.4. By End User
10. South America Drug Discovery Informatics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Mode
10.2.2. By Workflow
10.2.3. By Services
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Drug Discovery Informatics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Mode
10.3.1.2.2. By Workflow
10.3.1.2.3. By Services
10.3.1.2.4. By End User
10.3.2. Colombia Drug Discovery Informatics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Mode
10.3.2.2.2. By Workflow
10.3.2.2.3. By Services
10.3.2.2.4. By End User
10.3.3. Argentina Drug Discovery Informatics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Mode
10.3.3.2.2. By Workflow
10.3.3.2.3. By Services
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Drug Discovery Informatics Market: SWOT Analysis
